Compare PTCT & ZETA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTCT | ZETA |
|---|---|---|
| Founded | 1998 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 4.7B |
| IPO Year | 2006 | 2021 |
| Metric | PTCT | ZETA |
|---|---|---|
| Price | $82.28 | $20.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 12 |
| Target Price | ★ $80.65 | $27.67 |
| AVG Volume (30 Days) | 2.2M | ★ 7.2M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 264.48 | 63.16 |
| EPS | ★ N/A | N/A |
| Revenue | $264,734,000.00 | ★ $1,304,668,000.00 |
| Revenue This Year | N/A | $37.35 |
| Revenue Next Year | $17.70 | $16.29 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 36.19 | 29.72 |
| 52 Week Low | $43.18 | $13.74 |
| 52 Week High | $87.50 | $25.95 |
| Indicator | PTCT | ZETA |
|---|---|---|
| Relative Strength Index (RSI) | 65.15 | 55.42 |
| Support Level | $73.41 | $17.21 |
| Resistance Level | $87.27 | $25.43 |
| Average True Range (ATR) | 3.11 | 1.13 |
| MACD | 0.22 | 0.04 |
| Stochastic Oscillator | 75.57 | 81.22 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Zeta Global Holdings Corp is an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software. It serves enterprise customers across multiple industries, including financial services, insurance, telecommunications, automotive, travel and hospitality, and retail. Its Zeta Marketing Platform, or ZMP, is an omnichannel marketing platform with identity data at its core. The ZMP can analyze billions of structured and unstructured data points to predict consumer intent by leveraging sophisticated machine learning algorithms and the industry's opted-in data set for omnichannel marketing. The company operates in U.S, where it generates maximum revenue and Internationally as well.